The FDA-cleared UroLift System is a relatively new treatment for BPH, and it’s the only treatment that uses the Prostatic Urethral Lift (PUL) procedure. The UroLift System treatment is a proven, minimally invasive approach for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) that can get men off BPH medications and avoid major surgery. The UroLift System’s permanent implants, delivered during a minimally invasive outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.rnrnAs with any medical procedure, individual results may vary. Speak with your urologist to see if the UroLift System treatment is right for you. Most common side effects are mild to moderate and include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and/or the inability to control the urge. Most symptoms resolve within two to four weeks after the procedure.

The FDA-cleared UroLift System is the only treatment that uses the Prostatic Urethral Lift (PUL) procedure. UroLift for prostate issues is a proven, minimally invasive approach for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) that can get men off BPH medications and avoid major surgery. The UroLift System’s permanent implants, delivered during a minimally invasive procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.rnrnAs with any medical procedure, individual results may vary. Speak with your urologist to see if the UroLift System treatment is right for you. Most common side effects are mild to moderate and include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and/or the inability to control the urge. Most symptoms resolve within two to four weeks after the procedure.

The UroLift System consists of a delivery device and tiny permanent implants.rnu003culu003ern tu003cli aria-level=u00221u0022u003eThe UroLift Delivery Device is placed through the obstructed urethra.u003c/liu003ern tu003cli aria-level=u00221u0022u003eSmall UroLift Implants are placed to lift or hold the enlarged prostate tissue out of the way. The Implants are delivered through a small needle that comes out of the delivery device and into the prostate.u003c/liu003ern tu003cli aria-level=u00221u0022u003eThe UroLift Device is removed, leaving an open urethra that provides symptom relief.u003c/liu003ernu003c/ulu003ernOne unique aspect of the UroLift System is that it does not preclude retreatment or BPH treatments such as TURP or laser, should they be required in the future.

The UroLift System is a proven treatment option for BPH patients who are looking for an alternative to drugs or major surgery. You may be considering or scheduled for a TURP/Laser treatment, or are unhappy with or have stopped taking medications. The UroLift System is appropriate for patients seeking a minimally invasive treatment and are concerned about preserving their sexual function and their quality of life.

If you and your doctor decide that the UroLift System treatment is right for you, your doctor will provide the specific, detailed information relating to your condition. In general, the UroLift System is a minimally invasive treatment that entails minimal downtime. Your doctor will use the UroLift delivery device to deploy permanent implants to relieve obstruction caused by the u003ca href=u0022https://goldenstateurology.com/blog/why-treating-an-enlarged-prostate-early-will-prevent-overactive-bladder/u0022u003eenlarged prostateu003c/au003e that is pressing on your urethra. The procedure may be performed under local or general anesthesia and you may be given medication to feel comfortable during the treatment. Typically, no catheter and no overnight stay is required post-treatment.

After the treatment, almost all patients go home the same day without a catheter. There is minimal downtime post-treatment and many patients experience symptom relief in as early as 2 weeks. Patients may experience some urinary discomfort during the recovery period. The most common side effects may include light blood in the urine, some pain or discomfort when urinating, some increased urge to go and discomfort in the pelvis that typically resolve within two to four weeks after the procedure.

Sexual function has been preserved among the hundreds of patients treated in our clinical studies.1,2,3,4 This is a unique benefit of the UroLift System treatment compared with other BPH therapies such as TURP, laser, and even medication.

The primary contraindications are an obstructive or protruding median lobe of the prostate and a prostate with a volume of u0026gt;80cc.

Non-clinical testing has demonstrated that the UroLift Implant is MR Conditional. That means that you can be safely scanned in an MR system meeting the following conditions:rnu003culu003ern tu003cli aria-level=u00221u0022u003eStatic magnetic field of 3 Tesla or lessu003c/liu003ern tu003cli aria-level=u00221u0022u003eMaximum spatial gradient magnetic field of 1500 Gauss/cm (15 T/m) or lessu003c/liu003ern tu003cli aria-level=u00221u0022u003eMaximum MR system reported, whole body averaged specific absorption rate (SAR) of 4 W/kg (First Level Controlled Mode)u003c/liu003ernu003c/ulu003ernUnder the scan conditions defined above, the UroLift implant is expected to produce a maximum temperature rise of 2.4°C after 15 minutes of continuous scanning.rnrnIn non-clinical testing, the image artifact caused by the device extends approximately 15 mm from the UroLift Implant when imaged with a gradient echo pulse sequence and a 3 Tesla MRI system.rnrnPatient implant cards are provided to inform the patient that the UroLift implant is MR Conditional and can safely be scanned only under specific MR conditions.rnrnIf you have any questions about MRI safety, please consult your doctor.

Over 950 patient-years of clinical data has been presented in peer-reviewed publications to date demonstrating that the UroLift System is safe and effective. Clinical studies have been conducted in the United States, Canada, Europe and Australia.

No. The implants are placed on the anterior (front) side of the prostate, and a DRE is conducted on the posterior (back) side of the prostate. The implants are not expected to interfere in a DRE.

The first step is to make an appointment with your urologist to determine if you are an appropriate candidate for the treatment. Your physician’s office staff can work with you and your health plan to learn more about your healthcare benefits specific to the UroLift implant procedure.

Yes, all Medicare carriers provide benefits for the UroLift System when medically necessary. Discuss the UroLift System with your physician to determine if the UroLift treatment is an option for you.

UroLift is a safe, minimally invasive solution for treating BPH. By helping reduce obstructive prostate tissue, UroLift can help relieve symptoms of BPH without interfering with sexual function. Side effects are minimal and the procedure is quick to complete.

The Implants are intended to be permanent. The implant is made up of standard surgical implantable materials: a nitinol capsular tab, a stainless steel urethral tab, and polyethylene suture that holds the two tabs together. Your doctor can remove the urethral implant, if needed. The suture can be cut and the urethral endpiece can be retrieved with a standard grasper. The capsular tab will remain in place inside the body.

A urologist, a doctor who specializes in the treatment of diseases of the urinary system and sex organs, uses the UroLift System to treat urinary symptoms due to BPH. Comprehensive training is provided to the urologist prior to using the UroLift System.

NeoTract, Inc. manufactures the UroLift System. The company is based in Pleasanton, California.rnrnu003ciu003eSource: u003c/iu003eu003ca href=u0022http://demos.practisinc.com/neotract/urolift-systemu0022u003eu003ciu003e​u003c/iu003eu003c/au003eu003ca href=u0022https://www.urolift.com/patients/getting-started/patient-resources/faqs.htmlu0022u003eu003ciu003ehttps://www.urolift.com/patients/getting-started/patient-resources/faqs.htmlu003c/iu003eu003c/au003e

The UroLift System is available for sale in the United States, Europe, Canada and Australia.

Typically performed under general or local anesthesia for an outpatient procedure, UroLift recovery is a relatively fast process. You’ll need to stay home and rest for two to three days after the procedure. During this time, you may experience a burning sensation or blood in your urine, but this will subside as you heal. You’ll also need to avoid intense exercise, sexual intercourse, and other strenuous activities for two to three days after the procedure.

–This may include reduced sexual desire, fewer spontaneous erections — such as during sleep — and infertility.

Sometimes low testosterone causes insomnia or other sleep disturbances.

Various physical changes are possible, including increased body fat, reduced muscle bulk and strength, and decreased bone density. Swollen or tender breasts (gynecomastia) and body hair loss are possible. You may have less energy than you used to.

Low testosterone may contribute to a decrease in motivation or self-confidence. You may feel sad or depressed, or have trouble concentrating or remembering things.

Yes, The PRP Intimate shot is safe. No side effects have been reported from injecting a person’s own Platelet-Rich Plasma into their body.

Patients’ pain tolerances vary, however The PRP Intimate shot creates little, if any, pain. The areas are numbed with a topical cream, however some women may feel a pinching or stinging sensation while others don’t feel anything.

You may experience swelling of the area that has been injected that may cause extra sensitivity. The swelling will go down within a few days after the treatment.rnrnMost women will experience increased sensitivity of the clitoris and G-spot area resulting in stronger and multiple orgasms. Typically this may take up to 3-4 weeks. Some do not experience a notable difference but are still a candidate for a repeat injection. Women who have never had an orgasm have reported being multi-orgasmic following one PRP Intimate shot, even in their 60s.

The PRP Intimate shot can last for one to two years.

No. We apply local anesthetic prior to the procedure. During the PRP penile injection, you may feel some pressure that can be strange, but not necessarily painful. Most patients report a zero to two out of 10 on the pain scale.

A penis pump will be given to you to use 10 minutes twice daily for the six weeks following the procedure. This will ensure maximum stimulation to the penis, allowing the PRP penile injection to be more effective. In addition, your testosterone and all other hormones will be optimized, laying the foundation for sexual health. When needed, other medications will be considered to give you the best possible medical outcome.

For some, results from a PRP penile injection are experienced immediately. Most people will begin to see results within a few weeks, with maximum benefit after three full months.

For some men, the PRP injection can lead to noticeable increases in penis size. This occurs because ED and issues such as Peyronie’s disease can cause blood vessels to constrict and shrink. Penile PRP therapy stimulates the growth of new blood vessels and erectile tissue, boosting both length and girth.rnrnWhile results can vary, many men report gains in girth and, in some cases, length — especially when combined with a vacuum pump or supplements. Whether you’re looking for penile enlargement or just stronger erections, the PRP shot for ED delivers impressive results.

After your PRP for erectile dysfunction treatment, you’ll enjoy firmer erections and enhanced sexual function for up to two years. For even longer-lasting results, additional PRP injections can be administered as needed. This ensures you maintain your progress and continue to experience the benefits.

Researchers estimate that Peyronie’s disease may affect 1 to 23 percent of men between 40 and 70 years of age. However, the actual occurrence of Peyronie’s disease may be higher due to men’s embarrassment and health care providers’ limited reporting. The disease is rare in young men, although it has been reported in men in their 30s. The chance of developing Peyronie’s disease increases with age.

Some men with Peyronie’s disease (about 13 out of 100) get fibrosis in other parts of the body. The most common sites are the hands and feet. Dupuytren’s contracture, in which fibrosis occurs in the tissue of the palm, is one health problem linked to Peyronie’s disease. Dupuytren’s contracture may lead to permanent bending of the outer fingers. It isn’t clear what causes plaque to form in either disease, or why men with Peyronie’s disease are more likely to get Dupuytren’s contracture.

Cells taken from Peyronie’s plaques act like cancer cells in some ways, such as not dying normally and forming tumors when put into mice with no immune systems. But there has never been a case of Peyronie’s disease that has turned into cancer in a human.rnrnIf you have other symptoms that aren’t often seen with Peyronie’s disease, such as external bleeding, trouble peeing, or penile pain that lasts for a long time, your health care provider may take a sample of the tissue (biopsy) for further study.

The following factors may increase a man’s chance of developing        Peyronie’s disease:rnu003culu003ern tu003cli aria-level=u00221u0022u003eVigorous sexual or nonsexual activities that cause microscopic injury to the penisu003c/liu003ern tu003cli aria-level=u00221u0022u003eCertain autoimmune and connective tissue disordersu003c/liu003ern tu003cli aria-level=u00221u0022u003eA family history of Peyronie’s diseaseu003c/liu003ern tu003cli aria-level=u00221u0022u003eGeneral agingu003c/liu003ern tu003cli aria-level=u00221u0022u003eDiabetes-related erectile dysfunctionu003c/liu003ern tu003cli aria-level=u00221u0022u003eHaving had surgical treatments for prostate canceru003c/liu003ernu003c/ulu003e

Taking a history and performing a physical examination are used to diagnose patients with urinary incontinence.rnrnUsually a urinalysis is performed and, depending on the findings of the history and physical, further testing with either x-ray studies or a urodynamics study may be appropriate.rnrnGet a full evaluation prior to any treatment because the treatments are different due to the cause of the incontinence.

Yes, incontinence can come and go depending on its cause. For instance, some patients will complain of stress incontinence only when they have a severe cold with coughing or during periods of excessive activity.rnrnPatients with urge incontinence frequently report increased leakage during cold weather and sometimes related to dietary factors such as excessive fluid intake, particularly with products containing caffeine such as coffee.

In women, pregnancy and vaginal delivery is probably the most common cause of urinary incontinence. And in some cases, general aging may be the cause.